| A gene-expression signature as a predictor of survival in breast cancer MJ Van De Vijver, YD He, LJ Van't Veer, H Dai, AAM Hart, DW Voskuil, ... New England Journal of Medicine 347 (25), 1999-2009, 2002 | 7535 | 2002 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1605 | 2016 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1456 | 2006 |
| Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ... J clin oncol 29 (1), 17-24, 2011 | 620 | 2011 |
| Converting a breast cancer microarray signature into a high-throughput diagnostic test AM Glas, A Floore, LJMJ Delahaye, AT Witteveen, RCF Pover, N Bakx, ... BMC genomics 7 (1), 1-10, 2006 | 558 | 2006 |
| Gene expression profiles of primary breast tumors maintained in distant metastases B Weigelt, AM Glas, LFA Wessels, AT Witteveen, JL Peterse, LJ van't Veer Proceedings of the National Academy of Sciences 100 (26), 15901-15905, 2003 | 554 | 2003 |
| Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer B Weigelt, Z Hu, X He, C Livasy, LA Carey, MG Ewend, AM Glas, ... Cancer research 65 (20), 9155-9158, 2005 | 425 | 2005 |
| The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study S Mook, MK Schmidt, G Viale, G Pruneri, I Eekhout, A Floore, AM Glas, ... Breast cancer research and treatment 116, 295-302, 2009 | 357 | 2009 |
| Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van't Veer, ... The lancet oncology 8 (12), 1079-1087, 2007 | 331 | 2007 |
| The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer ME Straver, AM Glas, J Hannemann, J Wesseling, MJ van de Vijver, ... Breast cancer research and treatment 119, 551-558, 2010 | 319 | 2010 |
| Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment AM Glas, MJ Kersten, LJMJ Delahaye, AT Witteveen, RE Kibbelaar, ... Blood 105 (1), 301-307, 2005 | 282 | 2005 |
| Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. AM Glas, L Knoops, L Delahaye, MJ Kersten, RE Kibbelaar, LA Wessels, ... | 273 | 2007 |
| Validation of 70-gene prognosis signature in node-negative breast cancer JM Bueno-de-Mesquita, SC Linn, R Keijzer, J Wesseling, DSA Nuyten, ... Breast cancer research and treatment 117, 483-495, 2009 | 206 | 2009 |
| Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary HM Horlings, RK van Laar, JM Kerst, HH Helgason, J Wesseling, ... Journal of Clinical Oncology 26 (27), 4435-4441, 2008 | 198 | 2008 |
| The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age S Mook, MK Schmidt, B Weigelt, B Kreike, I Eekhout, MJ Van de Vijver, ... Annals of oncology 21 (4), 717-722, 2010 | 187 | 2010 |
| Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort BS Wittner, DC Sgroi, PD Ryan, TJ Bruinsma, AM Glas, A Male, S Dahiya, ... Clinical Cancer Research 14 (10), 2988-2993, 2008 | 170 | 2008 |
| A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ... Breast cancer research and treatment 133, 37-47, 2012 | 151 | 2012 |
| Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ... Annals of surgery 257 (6), 1053-1058, 2013 | 143 | 2013 |
| Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer S Tian, P Roepman, LJ Van't Veer, R Bernards, F De Snoo, AM Glas Biomarker insights 5, BMI. S6184, 2010 | 143 | 2010 |
| 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ... The Lancet Oncology 22 (4), 476-488, 2021 | 138 | 2021 |
Paul RoepmanHartwig Medical FoundationGeverifieerd e-mailadres voor hartwigmedicalfoundation.nl
